Mark Kellett
Mark Kellett publishes mostly in Neurology, Psychiatry and Mental health and Molecular Biology, on topics such as Neurological disorders and treatments, Neurofibromatosis and Schwannoma Cases and Meningioma and schwannoma management.
- World rank
- #1,657,455 of 7,710,434 ranked researchers
- Rank in United Kingdom
- #125,349 of 367,258
- Works
- 54
- Citations
- 3.7k
- Citations per work
- 68.1
What does Mark Kellett research?
Mark Kellett's work is mostly in Medicine (51%), Biochemistry, Genetics and Molecular Biology (7%), Neuroscience (5%).
Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.
The fields and subfields, with their numbers
- Health Sciences2750.7%
- Medicine2750.7%
- Everything else2036.7%
- Life Sciences712.6%
- 1Neurology29% of their works
- 2Psychiatry and Mental health8% of their works
- 3Molecular Biology7% of their works
- 4Epidemiology7% of their works
- 5Rheumatology7% of their works
- 6Cellular and Molecular Neuroscience5% of their works
Research topics
- Neurological disorders and treatments
- Neurofibromatosis and Schwannoma Cases
- Meningioma and schwannoma management
- Parkinson's Disease Mechanisms and Treatments
- Pharmacological Effects and Toxicity Studies
- Epilepsy research and treatment
- Glycogen Storage Diseases and Myoclonus
- Neurological and metabolic disorders
Which keywords describe Mark Kellett's research?
The keywords of their largest research topics: Epilepsy, Parkinson's Disease, Genetic Mutations, Basal Ganglia, Oxidative Stress, Neurodegeneration, Antiepileptic Drugs and Deep Brain Stimulation.
- Hyperglycemia
- Metabolism
- Teratogenicity
- Prenatal Exposure
- a-Synuclein
- Radiosurgery
- Tumor Suppressor
- Seizures
- Deep Brain Stimulation
- Neurodegeneration
- Basal Ganglia
- Parkinson's Disease
- Epilepsy
- Genetic Mutations
- Oxidative Stress
- Antiepileptic Drugs
- Neurofibromatosis
- Subthalamic Nucleus
- Meningiomas
- Dopaminergic Neurons
- Classification
- Status Epilepticus
- Glycogen
- Chorea
Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most.
All 24 words, with their numbers
- Epilepsy213 topics
- Parkinson's Disease182 topics
- Genetic Mutations152 topics
- Basal Ganglia142 topics
- Oxidative Stress142 topics
- Neurodegeneration132 topics
- Antiepileptic Drugs122 topics
- Deep Brain Stimulation101 topic
- Neurofibromatosis101 topic
- Seizures102 topics
- Subthalamic Nucleus101 topic
- Tumor Suppressor101 topic
- Meningiomas91 topic
- Radiosurgery91 topic
- Dopaminergic Neurons81 topic
- a-Synuclein81 topic
- Classification61 topic
- Prenatal Exposure61 topic
- Status Epilepticus61 topic
- Teratogenicity61 topic
- Glycogen51 topic
- Metabolism51 topic
- Chorea41 topic
- Hyperglycemia41 topic
Where does Mark Kellett work?
Mark Kellett's main affiliation in the publication record is University of Manchester, United Kingdom.
How many publications and citations does Mark Kellett have?
OpenAlex counts 54 works and 3,677 citations for Mark Kellett, an h-index of 23, ranking #1,657,455 of 7,710,434 researchers worldwide on the quality score.
Ranked on field-normalised excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.
Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.
Discussion
Ask a question or share a note about Mark Kellett. Posts are plain text and can be reported.